Dr. Liu Yi said that lung cancer (4890) double immune treatment for malignant pleural mesothelioma is effective for three-month reexamination

As a lung surgeon, the most commonly treated diseases are pulmonary nodules and lung cancer. Diseases are also diseases that we treat on a daily basis. There is a pleural disease that is much more malignant than some lung cancers. The name of this disease is malignant pleural mesothelioma. Have you heard of it before?

90% of patients with malignant pleural mesothelioma survive less than one year, Its treatment was at a plateau for many years before, and there was no further improvement. In the past two years, there is a new therapy, which is much better than traditional chemotherapy in patients with certain types of malignant pleural mesothelioma. This new type of therapy is double immunotherapy, that is, the combination of two immune drugs to treat malignant pleural mesothelioma.

There is a 71-year-old male patient who was in I treated him here, he was diagnosed with malignant pleural mesothelioma in another hospital, and I treated him with this latest therapy, and more than three months passed in a flash. This time he re-examined, and I also read the latest results. The effect is quite satisfactory. I plan to continue the treatment as planned tomorrow. I wish this patient can always achieve satisfactory results.